OBJECTIVES The value of the echocardiographic calcium score (eCS) was evaluated to predict cardiac events in a multicenter cohort of subjects without known coronary disease, who underwent stress echocardiography (SE) for suspected coronary artery disease (CAD).
C alcified plaques in the coronary arteries are markers of atheromatousplaque burden, which, in turn, is highly predictive of future cardiovascular events and mortality (1) . The coronary calcium score (2) , as assessed by cardiac computed or electron-beam tomography, has unequivocally demonstrated prognostic superiority (added to clinical risk scores) to screen asymptomatic subjects, compared with biomarkers (e.g., C-reactive protein) or established imaging parameters such as carotid intima-media thickness (3, 4) . Consequently, European guidelines on cardiovascular disease prevention (5) support the use of the coronary calcium score in asymptomatic adults at moderate cardiovascular risk. A number of studies have established that both aortic valve sclerosis/calcification (AVC) and mitral annular calcification (MAC), as detected by echocardiography, independently predict cardiovascular morbidity and mortality (6) (7) (8) (9) .
The use of echocardiographic semiquantitative calcium scores (eCS), which comprehensively assess aortic and mitral valves, papillary muscle, and the ascending aorta-and range from no visible calcium to severe and diffused calcium deposits-have also been associated with: 1) coronary and total cardiac calcium by computed tomography; 2) angiographically obstructive coronary artery disease (CAD); 3) worse prognosis in several patient subgroups; and 4) very recently, to ischemic stress echocardiography (SE) results (10) (11) (12) (13) (14) (15) (16) (17) (18) .
We aimed to evaluate the prognostic stratification value of a simple semiquantitative eCS to predict future hard cardiac events in a large and multicenter cohort of subjects without previously known coronary disease, who underwent SE for clinical purposes.
METHODS
PATIENT POPULATION. We retrospectively identified 1,303 patients from 5 European institutions and 1 U.S. institution who underwent clinically-indicated SE during a previous 6-month period (the patients were independently chosen in each center, based on local availability of digitally archived SE images for retrospective eCS assessment) for suspected CAD.
Exclusion criteria were: 1) known CAD and/or previous acute coronary syndrome or revascularization;
2) significant valvular heart disease or previous heart surgery: and 3) chronic renal insufficiency. in previous studies (10, 11, 14) and are detailed in The best cutoff for eCS to predict hard events from the receiver-operating curve was eCS >0, using the maximal Youden index method, with a sensitivity and specificity of 74% and 60%, respectively, and an area under the curve of 0.67 (SE 0.03).
PREDICTION OF HARD EVENTS BY CLINICAL AND
ECHOCARDIOGRAPHIC VARIABLES. Increasing age and diabetes mellitus were the clinical variables that were significantly associated with the risk of hard events at univariate analysis ( Table 3) , and their independent contribution to the stratification of prognosis was demonstrated at multivariate analysis ( Table 4 ).
The 3-year event rate for patients with eCS >0 was significantly less favorable compared with subjects with eCS ¼ 0 (9.8% vs 2.3%; p < 0.001). 
DISCUSSION
The main finding of our multicenter study was that for the first time we found a significant independent prognostic value of a semiquantitative eCS to predict hard cardiac events in a population of subjects with symptoms that required noninvasive evaluation for suspected CAD.
The prognostic yield of eCS was independent from clinical variables and stress wall motion data, but it was not able to discriminate them incrementally by comparison to the Harrell's C index of the models without and with eCS. In contrast, the addition of eCS was able to reclassify the risk of events, again compared with the model that included clinical and stress wall motion data, but this NRI method has recently been heavily criticized for its risk of frequent false positive results (21, 22) .
In contrast, the low sensitivity of C statistics for improvement in discrimination, in particular when the baseline comparison model has high C values (as the clinical þ stress wall motion model in our study), is well known (23, 24) .
In conclusion, in the absence of an associated sig- Noninvasive modalities for the diagnosis of CAD are key for risk stratification of symptomatic patients, and to identify higher risk subjects who could benefit more from invasive coronary angiography and possible subsequent revascularization (or in alternative maximal medical therapy). Transthoracic Tables 2 and 3 . Echo Calcium Score and Cardiac Events A P R I L 2 0 1 5 : 3 8 9 -9 6
